Public annual accounts

PHARMAPRODUCTS financials

Name: PHARMAPRODUCTS financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHARMAPRODUCTS, with comparable measures and links to available source documents.

Company overview

Registry number

0424935422

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHARMAPRODUCTS

2025 versus 2024

Operating line: €178,003
EBITDA: €111,880
Total assets: €501,031
Equity: €193,827

EBITDA margin +62.9% · Equity ratio +38.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€178,003	€111,880	€501,031	€193,827	-
202431 Dec 2024	€216,304	€146,124	€321,179	€124,587	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report